IRIDIAN ASSET MANAGEMENT LLC 13D and 13G filings for Axsome Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-18 3:45 pm Sale |
2021-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
IRIDIAN ASSET MANAGEMENT LLC | 0 0.000% |
-2,064,158 (Position Closed) |
Filing |
| 2021-02-04 08:32 am Purchase |
2020-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
IRIDIAN ASSET MANAGEMENT LLC | 2,064,158 5.500% |
2,064,158 (New Position) |
Filing |